Thursday, November 19, 2015

The Pharmacogenomics Journal - Table of Contents alert Volume 15 Issue 6

If you are unable to see the message below, click here to view.
The Pharmacogenomics Journal


TABLE OF CONTENTS

Volume 15, Issue 6 (December 2015)

In this issue
Review
Original Articles

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Submit your work to The Pharmacogenomics Journal

Covering multiple areas of medicine including cancer, cardiovascular, clinical immunology, precision & personalised medicine, The Pharmacogenomics Journal could be the place for your research. Reach an audience of over 77,000 with an Impact Factor of 4.229*.

*(2014 Journal Citation Reports® - Thomson Reuters, 2015)

Find out more: http://bit.ly/1W1vu5H
 
 

Review

Top

Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug–drug interactions

C Arimany-Nardi, H Koepsell and M Pastor-Anglada

Pharmacogenomics J 2015 15: 473-487; advance online publication, November 3, 2015; 10.1038/tpj.2015.78

Abstract | Full Text

Original Articles

Top

Genetic modifiers of response to glucose–insulin–potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial

K L Ellis, Y Zhou, J R Beshansky, E Ainehsazan, H P Selker, L A Cupples, G S Huggins and I Peter

Pharmacogenomics J 2015 15: 488-495; advance online publication, March 17, 2015; 10.1038/tpj.2015.10

Abstract | Full Text

Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials

H L Tang, W L Shi, X G Li, T Zhang, S D Zhai and H G Xie

Pharmacogenomics J 2015 15: 496-504; advance online publication, April 14, 2015; 10.1038/tpj.2015.16

Abstract | Full Text

Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer

E J Kap, P Seibold, S Richter, D Scherer, N Habermann, Y Balavarca, L Jansen, N Becker, K Pfütze, O Popanda, M Hoffmeister, A Ulrich, A Benner, C M Ulrich, B Burwinkel, H Brenner and J Chang-Claude

Pharmacogenomics J 2015 15: 505-512; advance online publication, March 17, 2015; 10.1038/tpj.2015.8

Abstract | Full Text

A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients

S Chen, I Laverdiere, A Tourancheau, D Jonker, F Couture, E Cecchin, L Villeneuve, M Harvey, M H Court, F Innocenti, G Toffoli, E Lévesque and C Guillemette

Pharmacogenomics J 2015 15: 513-520; advance online publication, March 17, 2015; 10.1038/tpj.2015.12

Abstract | Full Text

Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases

S Stremitzer, Y Sunakawa, W Zhang, D Yang, Y Ning, S Stintzing, A Sebio, S Yamauchi, S Matsusaka, R El-Khoueiry, J Stift, F Wrba, T Gruenberger and H-J Lenz

Pharmacogenomics J 2015 15: 521-529; advance online publication, March 10, 2015; 10.1038/tpj.2015.14

Abstract | Full Text

High-accuracy imputation for HLA class I and II genes based on high-resolution SNP data of population-specific references OPEN

S-S Khor, W Yang, M Kawashima, S Kamitsuji, X Zheng, N Nishida, H Sawai, H Toyoda, T Miyagawa, M Honda, N Kamatani and K Tokunaga

Pharmacogenomics J 2015 15: 530-537; advance online publication, February 24, 2015; 10.1038/tpj.2015.4

Abstract | Full Text

Neuronal cell adhesion genes and antidepressant response in three independent samples

C Fabbri, C Crisafulli, D Gurwitz, J Stingl, R Calati, D Albani, G Forloni, M Calabrò, R Martines, S Kasper, J Zohar, A Juven-Wetzler, D Souery, S Montgomery, J Mendlewicz, G D Girolamo and A Serretti

Pharmacogenomics J 2015 15: 538-548; advance online publication, April 7, 2015; 10.1038/tpj.2015.15

Abstract | Full Text

Advertisement
Ensure your latest research is seen by publishing in Molecular Psychiatry!

Submit to the number 1 psychiatry journal for six years running! Molecular Psychiatry has an Impact Factor of 14.496* and over 70,000 people will see your paper in their inbox. MP prides itself on publishing comprehensive original articles and expert reviews.

*(2014 Journal Citation Reports® - Thomson Reuters, 2015)

Find out more: http://bit.ly/1W1tudG
 
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: